New Delhi: Based on clinical trials data, India’s drug regulator has approved itolizumab, used to treat skin condition psoriasis, for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress, the Union health ministry said on Saturday. Considering the unmet medical needs in COVID-19, Drugs Controller General of India (DCGI) Dr V […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.
LIVE TV
